-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on United Therapeutics, Raises Price Target to $700

Benzinga·11/05/2026 20:39:48
Listen to the news
TD Cowen analyst Joseph Thome maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $675 to $700.